Pharmacologic Blockade of Angiopoietin-2 Is Efficacious against Model Hemangiomas in Mice
- 1 October 2006
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 126 (10) , 2316-2322
- https://doi.org/10.1038/sj.jid.5700413
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Molecular Pathogenesis of Vascular Anomalies: Classification into Three Categories Based upon Clinical and Biochemical CharacteristicsLymphatic Research and Biology, 2003
- Infectious AngiogenesisThe American Journal of Pathology, 2003
- Reactive oxygen generated by Nox1 triggers the angiogenic switchProceedings of the National Academy of Sciences, 2002
- Clonality and altered behavior of endothelial cells from hemangiomasJournal of Clinical Investigation, 2001
- Overexpression of VEGF 121 in Immortalized Endothelial Cells Causes Conversion to Slowly Growing Angiosarcoma and High Level Expression of the VEGF Receptors VEGFR-1 and VEGFR-2 in VivoThe American Journal of Pathology, 2000
- Hemangiomas in ChildrenNew England Journal of Medicine, 1999
- Spastic diplegia as a complication of interferon Alfa-2a treatment of hemangiomas of infancyThe Journal of Pediatrics, 1998
- Successful Multimodal Therapy for Kaposiform Hemangioendothelioma Complicated by Kasabach-Merritt Phenomenon: Case Report and Review of the LiteraturePediatric Hematology and Oncology, 1998
- Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathwaysProceedings of the National Academy of Sciences, 1997
- Endothelial cell tumors develop in transgenic mice carrying polyoma virus middle T oncogeneCell, 1987